Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 5:21 PM View:  | Avalo Therapeutics, Inc. (CERC) | 13-Nov-24 | Purchase | 500 | $13.00 | $6,500.00 | 100% 0.5K to 1.0K | |
| 14-Nov-24 5:21 PM View: | Avalo Therapeutics, Inc. (CERC) | 12-Nov-24 | Purchase | 500 | $12.50 | $6,249.50 | 100% 0 to 0.5K | |
| 17-Dec-21 5:02 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 15-Dec-21 | Grant | 2,000 | -- | -- | 18% 11.18K to 13.18K | |
| 10-Dec-21 8:00 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 10-Dec-21 | Grant | 2,000 | -- | -- | 22% 9.18K to 11.18K | |
| 14-Feb-20 5:00 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 12-Dec-19 | Grant | 2,000 | -- | -- | 28% 7.17K to 9.18K | |
| 08-Jan-19 9:00 AM View: | Brainstorm Cell Therapeutic... (BCLI) | 04-Jan-19 | Market Purchase | 1,475 | $3.39 | $5,000.25 | 26% 5.7K to 7.17K | (< 1%) |
| 28-Aug-18 4:33 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 27-Aug-18 | Market Purchase | 400 | $4.95 | $1,979.18 | 80% 0.5K to 0.9K | (78%) |
| 28-Aug-18 4:33 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 24-Aug-18 | Market Purchase | 1,000 | $4.91 | $4,906.00 | 250% 0.4K to 1.4K | (78%) |
| 16-Mar-18 6:06 AM View: | Brainstorm Cell Therapeutic... (BCLI) | 15-Mar-18 | Grant | 5,700 | $3.50 | $19,950.00 | 100% 0 to 5.7K | (80%) |
| 10-Feb-15 12:46 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 06-Feb-15 | Market Purchase | 6,000 | $6.75 | $40,500.00 | 55% 10.9K to 16.9K | (96%) |
| 04-Sep-14 1:10 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 03-Sep-14 | Market Purchase | 1,200 | $8.05 | $9,660.00 | < 1% 126.37K to 127.57K | (97%) |
| 04-Sep-14 1:10 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 02-Sep-14 | Market Purchase | 1,000 | $8.12 | $8,120.00 | < 1% 125.37K to 126.37K | (97%) |
| 07-Jul-14 4:39 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 24,600 | -- | -- | (100%) 24.6K to 0 | |
| 30-Jun-14 3:41 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 26-Jun-14 | Market Purchase | 3,200 | $8.34 | $26,688.00 | 3% 122.17K to 125.37K | (97%) |
| 09-Apr-14 3:28 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 08-Apr-14 | Market Purchase | 5,500 | $10.25 | $56,375.00 | 5% 116.67K to 122.17K | (97%) |
| 06-Feb-14 5:25 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 04-Feb-14 | Option Exercise | 115,113 | $11.89 | $1,368,570.00 | 468% 24.6K to 139.71K | |
| 06-Feb-14 5:25 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 04-Feb-14 | Market Option Sale (Planned) | 115,113 | $115.29 | $13,271,200.00 | (82%) 139.71K to 24.6K | 9% |
| 12-Jun-13 9:49 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 10-Jun-13 | Grant | 17,600 | -- | -- | 251% 7.0K to 24.6K | |
| 16-Aug-12 4:42 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 15-Aug-12 | Market Purchase | 950 | $18.68 | $17,746.00 | 16% 6.05K to 7.0K | 463% |
| 16-Aug-12 4:42 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 14-Aug-12 | Market Purchase | 50 | $18.55 | $927.50 | < 1% 6.0K to 6.05K | 467% |
| 18-May-12 4:28 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 17-May-12 | Market Purchase | 2,000 | $14.80 | $29,600.00 | 50% 4.0K to 6.0K | 611% |
| 28-Feb-12 5:14 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 24-Feb-12 | Market Purchase | 3,000 | $18.21 | $54,630.00 | 300% 1.0K to 4.0K | 478% |
| 13-Sep-11 9:42 AM View: | Furiex Pharmaceuticals, Inc. (FURX) | 09-Sep-11 | Market Purchase | 1,000 | $14.95 | $14,950.00 | 100% 0 to 1.0K | 604% |